Melanoma
News
Don’t delay: Cancer patients need both doses of COVID vaccine
For patients with cancer, immune response to the first dose of the Pfizer COVID-19 vaccine is reduced, and there is a need for a booster dose at...
News
AI detects ugly-duckling skin lesions for melanoma follow-up
Using wide-field photos, a new artificial intelligence program can pick out lesions worthy of follow up for potential melanoma.
Article
How has the pandemic affected rural and urban cancer patients?
News
Checkpoint inhibitors’ ‘big picture’ safety shown with preexisting autoimmune diseases
A Dutch nationwide study in melanoma patients found relative safety of immune checkpoint inhibitors for grade 3 immune-related AEs but does not...
Conference Coverage
Neoadjuvant immunotherapy shows promise in stage III melanoma
There is both preclinical and clinical evidence that neoadjuvant therapy may offer a survival advantage over adjuvant therapy.
Conference Coverage
Managing cancer outpatients during the pandemic: Tips from MSKCC
MSKCC has established guiding principles on how to manage cancer patients during the pandemic.
Article
COVID-19 vaccination in cancer patients: NCCN outlines priorities
Recommended timing of vaccination varies based on cancer and treatment type.
News
Does screening for skin cancer result in melanoma overdiagnosis?
When the COVID-19 pandemic first hit, cancer screening in the United States came to an abrupt halt.
Conference Coverage
Immune checkpoint inhibitors don’t increase COVID-19 incidence or mortality, studies suggest
Cancer patients treated with immune checkpoint inhibitors are not significantly more likely to develop or die from COVID-19, two studies suggest...
Conference Coverage
Neoadjuvant immunotherapy combo produces high response rate in melanoma
